By combining long-standing expertise with new research solutions, Charles River advances drug discovery for treatments of respiratory diseases. Our recently validated rodent models provide rapid, cost-effective methods for evaluating the potential efficacy of novel anti-inflammatory agents targeting chronic obstructive pulmonary disease (COPD) or asthma conditions.

Pharmacology Database

Filter model options by therapeutic area, indication and species. Matching database entries detail study methodology and endpoints. Browse now»

I need to...